Ozempic has quickly become one of the most talked-about weight loss drugs in recent years, praised for its effectiveness but increasingly questioned for its safety profile. As prescriptions surge, so do reports of side effects that go beyond the commonly expected nausea or appetite suppression. Patients and healthcare providers alike are beginning to weigh the benefits against emerging concerns.
Regulators are now taking a closer look at these risks, with growing evidence linking Ozempic and similar medications to more serious complications. From gastrointestinal problems to rare vision issues and mental health warnings, the conversation is shifting toward informed decision-making and safer alternatives.
